Pulling the Pfizer EUA would remove the only COVID-19 vaccine approved for all children from the US market. The Moderna ...

Palivizumab was the only approved therapy to prevent severe RSV disease in infants and young children until the approval of nirsevimab in 2023.

Inpatient mortality and adverse outcomes were significantly more likely among adults hospitalized with RSV infection vs seasonal influenza.

Senior officials in the Trump administration are encouraging vaccine skepticism − and it's jeopardizing the health of our ...